Treatment of depression in an adolescent with cardiomyopathy and arrhythmia

Tanidir C., Tanidir I. C., TUZCU V.

Cardiology in the Young, vol.25, no.7, pp.1418-1420, 2014 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 25 Issue: 7
  • Publication Date: 2014
  • Doi Number: 10.1017/s1047951114002303
  • Journal Name: Cardiology in the Young
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1418-1420
  • Keywords: Arrhythmia, Danon disease, depression, hypertrophic cardiomyopathy, mirtazapine
  • Istanbul Gelisim University Affiliated: No

Abstract

Patients with cardiomyopathy have a higher incidence of mood and anxiety disorders, resulting in greater probability for hospitalisation and increased risk for arrhythmia and death. We report a case of a 16-year-old boy with Danon disease, Wolff-Parkinson-White syndrome, and hypertrophic cardiomyopathy, who later developed depression and significant weight loss. The patient was successfully treated for his anxiety and depression with mirtazapine without any adverse cardiac effects.